Health Care Professional Site | Aimovig® (erenumab-aooe)

Aimovig^® is the #1 prescribed anti-CGRP therapy in the US, with over 3 million prescriptions written^1,*
Explore the clinical data
*Based on IQVIA prescription data for May 2018 to November 2020.¹
AHS treatment guidance for migraine patients
See the AHS guidance
Helping your patients get the resources to start Aimovig^®
Resources for your practice
Aimovig^® is covered for ≥90% of commercially insured and Medicare patients²

Aimovig^® Efficacy Data

AHS Guidance, Aimovig^® Initiation, and Safety Data

Resources to Start Aimovig^®

AHS = American Headache Society;
CGRP = calcitonin gene-related peptide.